1. Introduction
Engineered nanoparticles and innate immunity
The interaction of engineered nanomaterials (NMs) and nanoparticles (NPs) with the immune system and the possible induction of in ammation are of particular interest for two main reasons. First, we fl need to know more about the interaction of NPs with the immune system for understanding their potential health risks. Second, knowing how the immune system recognises and eliminates NPs will help with designing nanomedical products ( , drug delivery systems) not only e.g.
capable of modulating the immune responses, but also of escaping immune surveillance thereby exerting more e ectively their therff apeutic potential. Thus, in the current safe-by-design approach to nanotechnological and nanomedical products, assessing how NPs interact with the immune defences is a crucial issue in determining NP safety versus hazard for human as well as for environmental health . [1 4] -Most of the e orts of immunonanotoxicology have been aimed at ff the innate immune system, since the innate defence e ector cells and ff humoral factors are the rst that come in contact with foreign materials fi introduced into the body. Innate immune defences are particularly enriched in the tissues at the interface with the external environment (skin, mucosal linings of the respiratory and gastrointestinal tract), but NPs may also reach the blood, either upon transport and penetration through epithelial barriers, due to their small size, or, in the case of nanomedicines, because of intentional parenteral administration.
Interaction of NPs with the innate immune system can have different outcomes, mostly depending on the characteristics of the NPs [5 9]
-. The immune system reacts to foreign materials with defensive actions only if these are perceived as potentially dangerous. In the case of NPs, as for many other environmentally borne agents (such as dust particles and microorganisms), the body s biological barriers and ' elimination systems are in most instances su cient for excluding them, ffi and immune recognition mechanisms are not activated. In other cases, NPs may actually elicit an immune reaction that ends up in the destruction of the foreign material. The e ector cells that are mainly inff volved in this reaction are phagocytes, both resident tissue macrophages and blood-borne monocytes and polymorphonuclear leukocytes (PMN), which eliminate the NPs by phagocytosing and degrading them. In this context, it is important to be aware of the fact that NPs coming in contact with the innate immune system are never pristine ( as syn-" thesized ), and that once released in any environment they undergo " chemical and physical changes. Thus, they can agglomerate (a reversible phenomenon) or aggregate (irreversible) depending on their surface chemistry and on the environmental conditions (ionic strength, non-speci c protein adsorption, ) and interaction with other agents fi etc. present in the same environment. Aggregated NPs are usually in the microscale, are detected very easily by phagocytes and readily ingested and, in general, bigger NPs are taken up better than smaller ones. In contact with body uids, NPs can undergo signi cant surface changes. fl fi NPs can adsorb proteins and other plasma molecules and form a socalled bio-corona on their surface , with hydrophobic particles [10 12] -doing so more easily than hydrophilic NPs , and with a di erence [13] ff in the type of adsorbed proteins depending on the NP surface chemistry and hydration water . The surface coating of NPs then changes [14] their mode of interaction with innate immune cells, and we can identify three potential scenarios:
1 The bio-corona facilitates recognition and elimination by immune cells. This is the case, for instance, of NPs opsonised with immunoglobulins or complement components. 2 The bio-corona masks the NP foreign surface, and as a con-" " sequence there is poor recognition by immune cells or factors (a dysopsonic e ect)
. ff
[15] 3 Adsorption on the NP surface may alter the folding of the plasma proteins, which are then recognised by innate immune cells as danger signals, thereby inducing a signi cant in ammatory reacfi fl tion.
The modes of interaction of various NPs with di erent players of the ff innate immune system, and their sequelae in terms of the potential hazards for human health, are discussed in the present review.
Nanoparticle contamination with LPS
Toxicological studies are performed either , on human or in vitro animal-derived primary or transformed cells, or in di in vivo fferent animal models. Models are by de nition not perfect, and both fi in vitro and models have advantages and limitations. In imin vivo munonanotoxicology, it is very important to be aware of the model s ' limitations so as to avoid overinterpreting or even misinterpreting the results .
[16] One of the examples of possible misinterpretation of nanotoxicological results is the undetected presence of endotoxin in NP preparations. Contamination with bacterial lipopolysaccharide (LPS), or endotoxin, is frequently encountered in NP preparations, due to the high surface area and surface reactivity of NPs, and the ubiquitous presence of endotoxin. It is being appreciated in the eld of fi nanotoxicology that this is a major cause for false-positive reports about the in ammatory properties of NPs . The di culties are comfl [17 20] -ffi pounded by the fact that the available LPS tests are subject to artefacts [17, 19, 21] and that cryptic LPS can be transiently shielded by " " common bu er ingredients and detergents . Recent studies sugff
[22] gested that certain carbon-based nanomaterials may interfere with conventional endotoxin assays and alternative monocyte or macrophage activation tests may be required . [23] Human primary monocytes and dendritic cells (DCs) are extremely sensitive to LPS and show signi cant responses to as little as 10 pg/mL fi of LPS, a concentration that is considered endotoxin-free in some " " commercial products
. Unintentional contamination of NPs with [17, 24] minute amounts of LPS can induce a powerful in ammatory response in fl monocytes, which can be fully ascribed to the contaminant . Thus, [25] one mechanism by which NPs can impact innate immunity may be their propensity to unintentionally carry over and deliver LPS. Researchers must be aware of this issue when designing experiments and interpreting the data.
In addition to the classical LPS receptor complex, based on TLR4, MD2 and CD14
, an intracellular LPS receptor/sensor has been [26] described . It is now accepted that LPS is recognised within the [27 29] -cytosol by caspases 4 and 5 in humans and by caspase-11 in the mouse [30] . The presence of these cytosolic LPS sensors may be a factor to explain why a phase-III clinical trial with a TLR4 inhibitor failed to decrease mortality in patients with severe sepsis .
[31] The LPS-sensing caspases are expressed in immune cells from humans and mice . There are so far no reports that analyse whether [32] NPs, or LPS transported into the cell by NPs, can interact with these cytosolic LPS sensors. Since the LPS signal mediated by caspases leads to the activation of the in ammasome , this could, in principle, be fl
[30] another mechanism by which NPs can contribute to inducing an infl ammatory phenotype in monocytes and DCs.
All these observations and considerations call for great caution when attributing in ammation-inducing e ects to NPs both and fl ff in vitro in vivo, as the presence and e ects of LPS and of other bystander conff taminants, including other pathogen-associated molecular patterns (PAMPs), needs to be carefully controlled.
In ammation: a double-edged sword fl
In ammation is an adaptive response involving multiple cell types fl and soluble mediators that is triggered in response to infection, trauma, ischemia, toxic or other injury. The process normally leads to recovery and healing; however, chronic in ammation can lead to persistent fl tissue damage. In ammation is therefore a double-edged sword. The fl distinction between acute and chronic in ammation is important as the fl outcomes are vastly di erent. Yet, in the toxicological literature, this ff distinction is sometimes lost, perhaps due to the paucity of chronic studies, and a lack of information on the long-term impact of nanomaterial exposure as well as resolution of the in ammatory response, fl with tissue repair, or perpetuation of in ammation and tissue damage. fl Furthermore, it is important to note that in ammation is not synonfl ymous with infection; in the latter case, cells of the innate immune system are engaged to combat a microbial challenge, but in ammation fl can also be sterile and occur in the absence of microbial pathogens.
" " Hence, while in ammation is vital for the host defence against invading fl pathogens, an in ammatory response can also be triggered by nonfl microbial signals. Importantly, cells of the innate immune system may use the same pattern recognition receptors (PRRs) to sense PAMPs and host-derived damage-associated molecular patterns (DAMPs). PRRs, such as the Toll-like receptors (TLRs) and the nucleotide-binding oligomerisation domain (NOD)-like receptor NLRP3 (NOD-, LRR-and pyrin domain-containing 3) are used by immune cells to sense microorganisms, and these receptors are also activated by Neutrophils, or polymorphonuclear granulocytes, are granular leukocytes (white blood cells) possessing a nucleus with three or more lobes. They are the most short-lived cells in the bloodstream and the turnover is considerable. It has been estimated that more than half of the haematopoietic activity in the bone marrow is dedicated towards neutrophil production. Neutrophils are specialised in the phagocytosis of bacteria and other pathogens and are capable of phagocytosis on their own ( , without the participation of any other immune mei.e. chanism) or through antibody-or complement-mediated opsonisation of pathogens. Neutrophils are equipped with oxidative and proteolytic enzymes for the destruction of ingested pathogens and can also release the so-called neutrophil extracellular traps or NETs to capture bacterial and fungal pathogens . NETs consist of chromatin bres decorated [38] fi with antimicrobial proteins, including neutrophil elastase (NE), myeloperoxidase (MPO) and the anti-microbial peptide LL-37.
Eosinophils are another type of white blood cell associated with parasite infections as well as allergic diseases such as allergic asthma. Eosinophils are found in the circulation, but reside predominantly at mucosal surfaces where they can remain for weeks. Following activation, eosinophils degranulate releasing an array of granule proteins/ enzymes that are capable of causing tissue damage and dysfunction.
Basophils are the least common type of white blood cells. Basophils are involved in in ammation and have also been implicated in acute fl and chronic allergic diseases, including anaphylaxis, asthma, atopic dermatitis and hay fever. These cells contain the anticoagulant heparin and the vasodilator histamine. Like eosinophils, basophils play a role in both parasitic infections and allergies. The mast cell is a tissue-resident cell type very similar in appearance and function to the basophil, and best known for its role in allergy and anaphylaxis. The Fc region of IgE binds to mast cells and basophils, and antigen engagement of IgE triggers the release of histamine and other in ammatory mediators. fl
Nanoparticles, in ammation and asthma fl
Numerous studies have shown that engineered nanomaterials may induce in ammation. Due to the potential of inhalation exposure to fl nanomaterials in the workplace, many studies have focused on pulmonary responses to nanomaterials (reviewed in [46] to iron oxide (hematite) NPs in both healthy, non-sensitised mice and in sensitised mice with an established allergic airway disease and they could show that exposure to NPs increased the numbers of neutrophils, eosinophils, and lymphocytes in the airways of non-sensitised mice while, in contrast, exposing sensitised mice to hematite NPs induced a rapid and unspeci c cellular reduction in the alveolar space on day 1 fi post-exposure . These results indicate that cells in the airways of [46] individuals with established airway in ammation undergo cell death fl when exposed to hematite NPs. This study showed that sensitised and non-sensitised animals respond di erently to NP exposure and highff lights the importance of studying individuals with respiratory disorders when evaluating health e ects of nanomaterials. Rossi ff et al.
[47] showed, using the same BALB/c mouse model, that TiO 2 NPs elicited pulmonary neutrophilia in healthy mice while allergic pulmonary inflammation was dramatically suppressed in asthmatic mice exposed to TiO 2 NPs.
Carbon nanotubes (CNTs) have been extensively studied due to the concern of potential "asbestos-like" features . Shvedova . [48] et al [49] reported more than a decade ago that pharyngeal aspiration of singlewalled CNTs (SWCNTs) elicited unusual pulmonary e ects in C57BL/6 ff mice combining a robust, acute in ammation with early onset, profl gressive brosis and granuloma formation. Functional respiratory defi ficiencies and decreased bacterial clearance were found in mice exposed to SWCNTs. In contrast, equal doses (in weight) of ultra ne fi carbon black particles did not induce granulomas and caused a signi cantly weaker pulmonary in ammation . In a subsequent study, fi human SR-B1 speci cally recognised amorphous and crystalline silica, fi but not titanium dioxide or latex NPs, or monosodium urate crystals, although all of these particles exhibited a negative surface potential. Genetic deletion of SR-B1 and masking of SR-B1 by monoclonal antibodies showed that SR-B1-mediated recognition of silica was associated with caspase-1-mediated in ammatory responses. Furthermore, SR-B1 fl was shown to be involved in silica-induced pulmonary in ammation in fl mice . Thus, the study showed that SR-B1 is a silica receptor as-[61] sociated with canonical in ammasome activation. fl Caspases are enzymes best known for their critical role in apoptosis, a form of programmed cell death . However, a subgroup of these [62] proteases, comprising caspase-1, -11 and -12 in mice and caspase-1, -4, -5 and -12 in humans, controls the in ammatory response to pathogens fl and other noxious stimuli. These in ammatory caspases become actifl vated when recruited to in ammasomes. Canonical or prototypical infl fl fl ammasomes including the NLRP3 in ammasome activate caspase-1 in response to a variety of stimuli. By contrast, bacterial LPS, one of the strongest activators of the innate immune system, leads to the assembly of non-canonical in ammasomes through direct binding and activa-" " fl tion of caspase-4, -5 or -11. It is now understood that the so-called inflammatory caspases also induce a programmed cell death pathway, which is morphologically distinct from apoptosis, designated pyroptosis [63] . Recent studies revealed that the cleavage of gasdermin D is essential for pyroptosis induced by non-canonical in ammasome acti-" " fl vation . As highlighted in a previous section, it remains to be [64, 65] studied whether these non-canonical in ammasomes are activated by present in all tissues, in particular in the barrier tissues (respiratory and digestive mucosae, skin), where they have the role of surveillance and " " cleaning ,
, detecting and eliminating exogenous or endogenous i.e. anomalous agents, including microorganisms and senescent cells or misfolded proteins, that may harm the tissue physical and functional integrity. When these challenges are limited and weak, as in the majority of cases, the activity of resident macrophages is su cient for ffi eliminating the danger. However, in the case of extensive damage/invasion, resident macrophages can both proliferate , to increase in situ their number, and, most importantly, can produce alarm signals ( , e.g. chemokines) that recruit rst neutrophils and immediately afterwards fi in ammatory monocytes from blood.
fl
Monocytes can enter a tissue also in homeostatic conditions, for i.e. replenishing the pool of tissue resident macrophages, representing the cell reservoir for maintaining the adequate size of the resident macrophage population in some tissues, such as dermis and gut . [93, 94] 
Nanoparticles and macrophage polarisation
Macrophages consist of ontogenically distinct populations that can be grouped in two main types: tissue macrophages and monocyte-derived macrophages . Tissue macrophages are self-renewing, re-[95] sident and principally non-migratory phagocytes, serving as sentinels for tissue homeostasis and acquiring morphological and functional features based on the tissue within which they reside . Injury, [89, 96] infection or disease processes could induce macrophage activation and trigger the release of in ammatory cytokines and chemokines. These fl factors in turn may drive the recruitment of circulating monocytes into the tissue, which generate a large number of in ammatory monocytefl derived macrophages. Macrophages are plastic and adopt functional phenotypes according to signals derived from the surrounding microenvironment. This plasticity explains the opposing functions they can acquire during the di erent phases of an in ammatory reaction, an ff fl i.e, in ammatory phenotype (M1) during the development of the reaction, fl and an anti-in ammatory phenotype (M2) during the resolution of infl flammation. M1 are associated with defence against infections and resistance to tumour growth, while M2 are associated with immunosuppression, tissue remodelling and tumour progression . [97, 98] This plasticity is termed polarisation, and macrophages can be re-directed from one phenotype to the other by microenvironmental changes. Novel strategies to treat diseases aim at targeting macrophages polarisation by shifting the phenotypes towards M1 or M2 based on the circumstances ( , towards M1 for cancer treatment, or e.g. towards M2 in the chronic in ammatory diseases, such as auto-in ammatory and aufl fl toimmune diseases, metabolic syndromes, neurodegenerative diseases and so on). In this way, macrophages can be successfully translated into novel immunotherapy .
[99] NPs are foreign substances that, once inside the body, are mainly cleared by macrophages, especially by M2 macrophages . They [100] can be a useful tool for inducing macrophage activation, di erentiation ff or polarisation
. The e ects of NPs on macrophage polarisation [101] ff can be evaluated from two points of view: (1) the capacity of NPs to directly polarise macrophages to M1 or M2; (2) the propensity of NPs to shift the phenotype from M1 to M2 and , either directly or by vice versa delivering cargoes ( , polarising drugs/cytokines) to macrophages.
e.g. Both scenarios are discussed below.
Direct polarisation
Very limited literature exists on the direct e ects of NPs on macff rophage polarisation, and knowledge about the molecular mechanisms is practically missing. Most reports show the ability of NPs to induce M1 polarisation, while only few describe M2 polarisation. These studies have been performed almost exclusively on human (THP-1 and in vitro U937) and murine (RAW264.7 and J774.A1) monocyte/macrophage cell lines, and on murine macrophages isolated from peritoneal ex vivo cavity, liver, lung, synovium . A recent study showed that M-CSF-stimulated M2 human macrophages were more prone to take up mesoporous silica particles of different sizes when compared with GM-CSF-stimulated M1 macrophages [110] . Evidence was provided for a role of speci c phagocytosis refi ceptors, including the class A scavenger receptor (SR-A) as well as the mannose receptor CD206, and the study suggested that more than one receptor may be involved in macrophage uptake of silica particles [110] . Interestingly, in a recent study using mouse strains that in vivo are prone to Th1 immune responses (C57BL/6) Th2 responses versus (BALB/c) NPs were cleared at di erent rates. Macrophages from Th1 ff strains took up fewer particles than macrophages from Th2 in vitro strains, and the authors discussed that particle clearance likely in vivo involves multiple receptors . Furthermore, using gold NPs, . XL-MSNs showed signi cantly higher loading of model proteins fi with di erent molecular weights compared to conventional small pore ff MSNs. XL-MSNs were used to deliver IL-4, which is an M2-polarising cytokine and very quickly degraded , to macrophages and poin vivo larise them into anti-in ammatory M2 macrophages . IL-4-loaded fl in vivo XL-MSNs induced a low level of ROS production and no in ammatory fl cytokines in RAW264.7 cells and in peritoneal macrophages in vitro extracted from mice after intravenous administration .
[116] The shift from M1 to M2 can also be induced by HA-PEI/pDNA, NPs of hyaluronic acid-poly (ethyleneimine) (HA-PEI) encapsulating a plasmid DNA expressing M2-polarising cytokines such as IL-4 and IL-10. The e ciency of these NPs to deliver M2-polarising signals has been ffi tested on murine J774A.1 cells, which after exposure showed increased M2 markers (increased Arg/iNOS ratio, higher CD206 and CD163 expression), and decreased M1 markers such as CD86
. Moreover, [95] C57BL/6 mice intraperitoneally injected with LPS and IFN-(M1-polarising agents) showed down-regulated expression of iNOS and upregulated expression of CD163 upon exposure to HA-PEI/pDNA . [117] On the same line, LPS-stimulated peritoneal macrophages exposed to mir-223-expressing HA-PEI NPs (mir-223 is an anti-in ammatory fl miRNA) had lower expression of iNOS and of the in ammatory cytofl kines TNF-, IL-1 and IL-6, and higher expression of Arg-1, thereby shifting the macrophage phenotype from M1 to M2 . [118] In addition to the use of NPs as vehicle for transfecting macrophages with anti-in ammatory miRNAs or plasmid DNAs, NPs can be also used fl as carriers for the direct delivery of macrophage-polarising drugs/factors. This use of NPs is mainly being studied in the eld of tumour fi treatment. The tumour microenvironment induces the M2 polarisation of tumour-associated macrophages (TAM), and a high M2/M1 ratio is clinically associated with poor prognosis in many types of cancers. Thus, the use of NPs to shift the macrophage phenotype from M2 to M1 (for inhibiting the tumour-promoting M2 activity and inducing the M1 tumour killing capacity) is one of the most promising areas of nanomedicine . As an example, in recent studies albumin-bound pa-[119] clitaxel (nAb-PTX) loaded into porous silicon multistage nanovectors (MSV) were tested to prove the e ect on macrophage polarisation and ff on the transport and anti-cancer e cacy of the drug. The macrophages ffi stimulated with MSV-nAb-PTX and macrophages extracted from liver metastatic lesions of MSV-nAb-PTX pretreated mice, both showed an increased level of M1 markers (IL-1 , IL-6, TNF-, CCL2, CCL5, .). etc Thus, the treatment with MSV-nAb-PTX drove macrophages from the tumour-induced non-cytotoxic M2 phenotype to the tumouricidal M1 phenotype. Importantly, by using co-cultures of macrophages with breast cancer tumour cells (3D spheroids) and in vivo in a mouse model of metastatic breast cancer, it has been observed that MSV-nAb-PTX accumulated in macrophages and increased their motility towards the centre of the tumour lesion, thereby promoting the targeted delivery of therapeutic drug . Overall, however, it is important to consider [120] that targeting cytotoxic drugs to macrophages may have signi cant fi drawbacks,
. direct toxicity for the macrophages themselves, ini.e cluding Kup er cells and other tissue resident macrophages, thereby ff lowering innate defences and increasing the risk of infections.
Nanoparticles and modulation of innate immune memory
The ability of innate immune system to develop an immunological memory is a recent re-discovery in immunology, a concept that goes against the dogma that only adaptive immunity can develop memory. Innate memory is a well-known phenomenon in plants and invertebrates, organisms that lack a classical adaptive immune system i.e.
[121,122], while only recently it has been fully described also in mammals. Brie y, the innate memory concept has arisen from the obfl servation that innate immune cells such as NK cells and monocytes/ macrophages can mount an increased ( trained immunity ) or de-" " creased ( tolerance ) response to secondary infections (independently " " on the nature of the rst stimulus) in terms of increased or reduced fi secretion of in ammatory mediators ( , cytokines and chemokines) fl i.e. [123, 124] . Thus, innate memory provides protection against reinfection in a T/B cell-independent manner.
There are several important di erences between innate and adapff tive immune memory. rapid and potent than primary response in the adaptive memory. 3 The innate memory is triggered by any molecule or stressful event ( ., molecules from microorganisms or produced by damaged host e.g cells, metabolic compounds, pollutants, ) upon a second exetc. posure to the same or di erent agent/event, while the adaptive ff memory is speci c for a given antigen, upon a second exposure to fi the same. 4 Gene rearrangement (somatic recombination of gene segments) is the underlying mechanism of the adaptive immune memory, while a non-speci c epigenetic reprogramming is at the basis of innate fi memory ( , DNA methylation, histone modi cations, miRNA exe.g. fi pression).
The emerging concept of innate memory represents a paradigmatic change in immunity. Its putative role in resistance to reinfection and its implication will widen our knowledge of the pathogenesis of both acute and chronic in ammatory diseases, and may represent the next step in fl the design of future vaccines . At present, the epigenetic e ects of NPs are being studied in ff in vivo mouse models (BALB/c, C57BL/6) and in di erent human and in vitro ff murine transformed cell lines of di erent origin, such as HaCaT ff (transformed human epidermal keratinocytes), HeLa (human cervical carcinoma), MRC7 (human breast carcinoma), THP-1 and RAW264.7 (human and mouse macrophage-like tumour cells), A549 (human lung carcinoma), and several others. Focusing our attention only on the effects of NPs on innate immune cells, very little has been studied so far. For instance, it has been observed that unmodi ed luminescent semifi conductor NPs, or quantum dots (QDs), used for uorescence-based fl imaging (for their capacity of a strikingly rapid accumulation in the nuclei and nucleoli of living human cells), provoked histone modi cafi tion in THP-1 cells. In particular, QDs did preferentially bind to the positively charged core histone proteins, as opposed to the DNA or RNA, provoking an increased formation of QD/protein aggregates [133] . In the murine RAW264.7 and in the human THP-1 macrophagelike tumour cell lines, exposure of cells in culture to TiO 2 NPs (generally used for sunscreen lotions) or CuO NPs (generally used as chemical sensors) induced changes in the expression levels of genes involved in the DNA methylation machinery, in a cell-, dose-and NP-dependent manner, and an increase in the expression level of and , the LINE-1 ALU two most abundant transposable elements in mammalian genomes [134] . A series of studies, performed on human blood cells to assess the e ect of ambient particulate matter (PM) with aerodynamic diameter ff 2. . Moreover, in these previce versa liminary experiments it has been observed that not only naïve cells but also primed cells (either with LPS or with Au NPs) failed to respond to Au NPs by producing TNF-. Thus Au NPs were unable to directly induce monocyte activation, but nevertheless they could induce a memory status that changed the cell reactivity to a subsequent challenge . Apart from these preliminary results, the role of NPs in [138] modulating innate memory is practically unexplored.
In conclusion, we should consider two main issues regarding the epigenetic e ect of NPs (and genotoxicity in general) on innate immune ff cells, especially on monocytes and macrophages. First, the majority of the epigenetic studies have been performed on cell lines rather than on human primary cells, and we must be aware that cell lines are not normal cells and that they might not react as normal cells do .
[16] Second, most of the studies still did not take in account the importance of LPS contamination of the NPs. Indeed, LPS is a bacterial product, ubiquitously present as contaminant, which can elicit powerful infl fl ammatory reactions in human monocytes. The in ammatory activation by LPS takes place through the reprogramming of gene expression by di erent mechanisms including epigenetic modi cations. Moreover, ff fi epigenetic modifi cations are at the basis of the phenomenon of LPSinduced tolerance in these cells . Thus, the undetected presence of [139] even minute amounts of LPS may induce epigenetic phenomena by itself. Accordingly, caution should be exercised when designing studies on the e ects of NPs on innate immune cells, in particular human ff monocytes, to avoid misinterpretations due to the undetected presence of biologically active contaminants such as LPS (see above). Nevertheless, assessing the epigenetic changes induced by NPs in human innate immune cells is an issue that needs attention and that should be taken into account when examining the safety pro le of NPs. fi A graphic representation of how NPs may modulate monocyte/ macrophage functions is reported in . Fig. 2 
Dendritic cells

Dendritic cells and nanoparticles
Dendritic cells (DCs), like macrophages, are mainly located close to body surfaces and possess an impressive array of extra-and intra-cellular receptors that recognise di erent stimuli, including PAMPs and ff DAMPs. These properties often make macrophages and DCs the rst fi types of professional immune cell that recognise NPs and that can respond to them by initiating immune reactions. Indeed, NPs are the ideal candidates for being recognised by tissue-resident macrophages and DCs, and by incoming blood monocytes: they are in the right size range, they are non-self, and they enter the same routes as pathogens. The via reaction to danger signals, in cases in which NPs are able to deliver them, are however di erent. While tissue-resident macrophages are ff usually relatively unreactive, except by producing chemokines, incoming monocytes (recalled by the chemokines) can produce a wealth of in ammatory cytokines and other factors, and resident DCs migrate fl to the lymph nodes where they are able to interact with naïve T cells and present non-self peptides on MHC II complexes, produce a number of cytokines and eventually drive antigen-speci c T cell polarisation fi towards speci c subsets.
fi Although DCs are cells that link innate to adaptive immunity, they are cells of the innate immune system and contribute directly to in ammatory processes, which is the main topic of the present section. [149] [150] these cells are not truly identical to the original cell type, so their reliability will depend on which parameters are being observed. Studies on nanoparticle interactions with DCs have used most frequently either bone marrow-derived DCs (BMDCs) from mouse or human blood monocyte-derived DCs (MoDCs), which can both be di erentiated ff in vitro to a peripheral DC-like phenotype. Primary DCs are available in limited amounts by sorting from human blood, and they are also addressed by animal models . It is important to consider the difin vivo ferent models when comparing data from studies in this eld. fi
Nanoparticle toxicity towards dendritic cells
We can expect cytotoxic e ects of some NPs because DCs are phaff gocytic, so substantial amounts of NPs may end up within these cells. DCs are central players at infection sites and they need to live long enough to interact with T cells in the draining lymph node. Based on their function, it can be expected that DCs should be relatively resistant to toxic entities. A study by Horev-Azaria
. has compared the cyet al totoxicity of cobalt-ferrite NPs acting on lung slices from rat, on cell lines from lung (A549, NCIH441), liver (HepG2), kidney (MDCK) and intestine (Caco-2, TC79), on lymphoblasts (TK6) and on primary mouse DCs . With the limitations of the cytotoxicity assays used, DCs [151] were, together with HepG2 cells, the least sensitive among the cells studied, with no cytotoxicity being observed at 1 mM (1. . These and other observations support the assumption that [157] cytotoxicity towards the rather robust DCs is not a major factor of NP immunotoxicity, since other cell types are likely to be a ected at lower ff doses.
E ects on cytokine production ff
DCs can produce in ammatory cytokines, which may be upregufl lated by NPs. For example, treatment with negatively charged polyethylene glycol (PEG)-coated nanogold led to increased TNF-production in MoDCs, while positively charged polyvinyl alcohol-coated nanogold induced IL-1 release in presence of LPS . The same [154] study reported that treatment of MoDCs with the various particles led to reduced TNF-production in the presence of LPS, which is in line with a report on e ects of magnetic NPs on mouse BMDCs, where LPS also ff led to reduced TNF-secretion . Nanogold was shown to modify [158] the production of T cell-stimulating cytokines by DC in a size-dependent manner: 10 nm particles inhibited LPS-induced production of IL-12 by human MoDCs, resulting in increased Th2 di erentiation, while 50 nm ff particles supported Th17 polarisation . The molecular mechan- [152] isms behind these e ects are not understood, but it is clear that NPs can ff a ect the production of in ammatory cytokines by DCs both positively ff fl and negatively. For mouse BMDCs, a role of purinergic signalling in cytokine production was reported . Stimulation with 30 nm silica [159] NPs induced production of IL-1 and of IL-18. Cytokine production was inhibited by a speci c antagonist to the purinergic receptor P2X fi 7 [159] .
Nanoparticle uptake by dendritic cells and antigen processing
A material-independent size range of 20-40 nm has been found to be optimal for the uptake of NPs into DCs , a property that allows [160] using size to target speci c populations of DCs and macrophages . fi
[161] More recently, uptake into lysosomes has received attention. Depending on their size, shape and chemistry, NPs reaching lysosomes can induce [163] The release of danger signals originating from lysosomes depends on the NP properties, thereby allowing us to optimising vaccine design, but it should also facilitate prediction of adverse e ects. In order to induce ff a robust anti-tumour response upon NP-mediated delivery of tumour antigens to DCs, danger signals , however, are not su cient. To per se ffi achieve a cancer-speci c response, cross-presentation is desired, in fi which antigen taken up from outside the cell is processed and presented in the context MHC I, rather than MHC II. Cross-presentation is facilitated by speci c properties of the NPs. For instance, an amphiphilic, fi pH-sensitive galactosyl dextran-retinal nanogel was used to enhance antigen release from lysosomes of BMDCs, resulting in enhanced crosspresentation . In the acidic lysosome environment, the retinal was [163] released from the from pH-sensitive hydrazine bonds in the entrapped galactosyl dextran-retinal nanogel, leading to enhanced DC maturation via engagement of the retinoic acid receptor. Another study showed that alkalisation of lysosomes caused by cationic liposomes was responsible for reduced degradation of a delivered antigen in BMDCs, which leads to enhanced cross-presentation and cross-priming of CD8 + cells
. [164] It should be noted that lysosomal rupture is not necessary for NPs to have an e ect on lysosomal functions. BMDCs that had taken up ovalff bumin-coated 20 nm polystyrene particles showed reduced antigen degradation, but no lysosomal leakage, changes in surface markers, cytokine pro le or strength and type of CD4+ T cell activation pro le fi fi [165] . In these functions, innate immune factors (danger signals, inflammatory cytokines) are part of the extra-and intracellular environment that determines the outcome of exposure to an antigen. The resulting adaptive immune response towards nanoparticles has been discussed in detail elsewhere .
[4]
The complement system
The complement system is a major component of innate immunity that plays an important role in non-speci c defence by intercepting a fi wide repertoire of invading pathogens and particulate matters as well as the body s own damaged and aged cells, and other self-e ete mate-' ff rials . The prime functions of complement in immune surveillance [166] are accomplished through opsonisation processes, lysis, chemotaxis and controlled in ammation . The complement system is also a fl [166 168 ] -functional bridge between innate and adaptive immunity, and crosstalk with other biological cascades ( , the coagulation cascade) to maine.g. tain homoeostasis
. On the other hand, uncontrolled com- [167 169 ] -plement activation is detrimental, and could cause tissue damage as well as contributing to disease pathogenesis ( , tumour growth) e.g.
[166 171]
-. The complement system is composed of at least 35 soluble and membrane-bound proteins ( , receptors and regulators) . e.g.
[166,168] Complement activation is a proteolysis-based activation cascade, which proceeds through three main pathways (alternative, classical and lectin pathways)
. Each pathway is triggered di erently, but they [166, 168] ff converge at the step where the third complement protein (C3) is cleaved through assembly of C3 convertases that generate the same set of e ector molecules . Enzymatic cleavage of C3 generates ff [166 171 ] -the 9 kDa anaphylatoxin C3a and the opsonic component C3b, which forms a covalent bond (usually an ester or an amide) with the complement-activating surface . This facilitates particle recogni- [166, 168] tion by complement receptor 1 (CR1) expressed by blood leukocytes ( , neutrophils, monocytes) and tissue macrophages ( , Kup er e.g. e.g. ff cells, splenic marginal zone, and red-pulp macrophages) . [166, 172] Inactivation of C3b, however, occurs rapidly forming iC3b, C3c and C3dg. These degradation products also serve as ligands for other complement receptors expressed by leukocytes and macrophages [166, 172] . Depending on the species, erythrocytes and platelets may also bind complement-opsonised NPs through their respective complement receptors . [173, 174] Activation of the terminal pathway of the complement system by either classical, lectin or alternative pathways results in C5 cleavage, which releases the highly potent anaphylatoxin C5a, and eventual formation of the membrane attack complex (C5b-9)
. Both [166 169 ] -C3a and C5a can activate mast cells and basophils, leading to the release of thromboxane A2 as well as other in ammatory mediators. fl Accordingly, uncontrolled complement activation by some NPs may contribute towards injection (or infusion)-related reactions seen in animals and human subjects . However, a recent study [170, 171, 175] [176] has shown a transitional link from robust clearance of NPs by strategically placed macrophages in the systemic circulation to adverse injection reactions, and independent of complement activation. There are also indications that intratumoural accumulation of NPs may promote tumour growth . This is suggested to arise through NP- [170] mediated intratumoural complement activation, and C5a liberation [170] . Indeed, C5a is a chemoattractant molecule recruiting immune cells with immunosuppressive activities ( , regulatory T cells, M2 e.g. macrophages, PMNs) into the tumour site . Finally, C5b-9 [177, 178] complexes have the capacity to elicit non-lytic stimulatory responses from vascular endothelial cells, thereby modulating endothelial regulation of haemostasis and in ammatory cell recruitment . fl [179] 5.1. Complement activation by nanoparticles 5.1.1. The classical pathway NPs, depending on their size, morphology, structural defects, and surface characteristics, may trigger complement activation through any of the three (or combinations of) complement pathways ( ). [180] Fig. 3 The classical pathway of complement is triggered when the rst comfi plement protein (C1, which consists of the multimeric pattern recognition molecule C1q and a heterotetramer of proteases C1r and C1s [166, 168] ) binds either directly to a reactive surface ( , polyanionic e.g. surfaces such as sulphated polystyrene NPs , pristine carbon na- [181] notubes ) or to particles that have been primed with im- [182, 183] munoglobulins ( , liposomes bound to natural anti-phospholipid ane.g. tibodies , IgG-functionalised iron oxide NPs ) or with C- [184] [185] reactive protein ( , lysophosphatidylcholine-based liposomes ). e.g.
[186] Accordingly, C1 activation proceeds when bound C1q undergoes a conformational change, which results in a calcium-dependent activation of the C1r module, which in turn triggers its associated C1s to generate an active serine protease that cleaves the fourth and second complement proteins (C4 and C2, respectively), leading to the assembly of the classical pathway C3 convertase . [166, 168] C1q binds a single IgG Fc segment with very low a nity ffi (K d 10 4 M) . However, for multivalent C1q binding and C1 [186] activation, IgG clustering is necessary , where two IgG molecules [187] must be within 10-40 nm of each other to form a stable binding site for C1q. On the other hand, a single pentameric or hexameric IgM (without J chain) can activate C1, but this requires a change in the immunoglobulin conformation from planar (as observed in solution) to a " " staple form to make e cient contact with the C1 complex . ffi
[188] Accordingly, particle size (and hence curvature) could play a modulatory role in complement activation through IgM binding. For instance, dextran-coated iron oxide particles of 100-250 nm trigger classical pathway activation e ciently on binding of anti-dextran IgM ffi antibodies, whereas larger (600 nm) particles poorly activate complement despite binding pentameric IgM as e ectively as 100-250 nm ff particles . With 100-250 nm particles, bound IgM molecules ap- [189] parently assumes staple conformation with su cient strain (a mea-" " ffi sure of bending of the C 1 module of IgM and variable domains relative to Fc5 disk) that triggers C1 activation, whereas the moderately curved 600 nm particles are not able to de ect the planar conformation of IgM fl in solution into the staple-like conformation . It is plausible " " [189] that, for particles with diameters in the range of the cross-sectional diameter of the IgM molecule itself ( 40 nm), high-a nity interacffi tions may induce su cient strain on IgM to trigger C1 activation. ffi Recent studies have also shown activation of the classical complement pathway by graphene oxide in solution and immobilised forms [190] . In solution, there was a decrease in graphene oxide-mediated complement activation with decreasing surface oxygen content and altered oxygen functionality. However, with immobilised graphene oxide complement responses were reversed, and increased with decreasing oxygen content . Another interesting example of com- [190] plement activating particles is exosomes. Metastatic and non-metastatic cell line-derived exosomes have shown increased complement activation (through calcium-sensitive pathways) compared with non-malignant cell line exosomes . These observations are presumably re- [191] lated to di erences in expression of complement regulatory proteins ff such as decay-accelerating factor and CD59 between these exosomes [192] . More potent complement activation by both metastatic and nonmetastatic malignant cell-derived exosomes may be a contributing factor in promoting tumour growth through C5a-mediated recruitment of immunosuppressive cells as well as a suggested role for complement in endothelial cell retraction . The latter phenomenon may pro- [193] mote extravasation of circulating tumour cells, and increase metastatic spread. This suggestion is also in line with a markedly reduced sti ness ff of malignant cell line-derived exosomes compared with their non-malignant-derived counterparts . [194] 5.1.2. The lectin pathway NP triggering of the lectin pathway usually occur on binding of any of the pattern recognition collectin molecules mannose-binding lectin (MBL), colins and collectin 11
. MBL contains a colfi [166, 168, 194 ] lagen-like region, which forms homo-trimeric units of MBL polypeptide chains . These units are able to form larger oligomers of 3 8 units [195] - [196] . MBL binds predominantly to carbohydrates with 3-and 4-hydroxyl groups in D-mannose and -acetyl-
. Ficolins H and L show speci city for [194] fi NAcGlc, whereas collectin 11 binds L-fucose and D-mannose in a calcium-dependent manner. These pattern recognition molecules are associated with serine protease zymogens, the MBL-associated serine proteases (MASP) 1, 2 and 3, and two non-enzymatic fragments of MASPs (Map19, and Map44, which is an alternatively spliced product of the gene, and a competitive inhibitor of the binding of the MASP1/3 recognition molecules to all three MASPs)
. Binding of [166, 168, 187] the lectin pathway pattern recognition molecules to an activating surface activates MASPs and trigger complement cascade. The exact molecular details by which MBL, colins and collectin 11 trigger MASP fi activation on NPs are still poorly understood, but presumably arise through polyvalent interactions with surface bound ligands and conformational changes, which in turn may be modulated by surface curvature, ligand spacing and its architectural display. Regardless, it has been proposed that MASP1, once activated, cleaves MASP2
. Ac- [197] tivated MASP2, in turn cleaves C4 to generate C4b. The latter binds the second complement protein (C2), which is then cleaved primarily by MASP1, and to lesser extent by MASP2, to form the C3 convertase C4bC2a, which is identical to the classical pathway C3 convertase.
Examples of lectin pathway-activating surfaces include carbon nanotubes coated with methoxypoly(ethylene glycol)-phospholipid conjugates , dextran-coated iron oxide nanoworms , [198, 199] [ 200 202 ] -block co-polymer micelles , and block copolymer-coated nano- [203] particles , but there are species di erences. For example, in [181] ff mouse, dextran-coated iron oxide nanoworms predominantly trigger complement through binding of MBL-A/C, whereas in human serum MBL/MASPs play a moderate part in complement activation by nanoworms . Modi cation of the dextran shell of nanoworms with a [200] fi crosslinking-hydrogelating agent blocks lectin pathway activation and decreases C3b/iC3b opsonisation by 90% in mice, but not in human sera . Subsequently, these modi cations showed minimal [201, 202] fi nanoworm recognition by leukocytes and liver macrophages, and increased circulation half-life of intravenously injected nanoworms by 60-fold in mice . Another interesting example is polystyrene NPs [201] coated with a block copolymer of ethylene oxide-propylene oxide (poloxamine 908) . This copolymer has repetitive recognition [181] patterns of relative polarity and hydrophobicity. Depending on NP curvature and adsorbed poloxamine 908 quantities, copolymer con gfi uration may change, and this subsequently changes displayed patterns of polarity and hydrophobicity. It has been shown that surfaces displaying a at copolymer con guration trigger complement through the fl fi C1q-dependent classical pathway, whereas changing the copolymer con guration to mushroom-brush architectures triggers complement fi " " activation through the lectin pathway . The dynamics of the [181] terminal regions of surface projected poloxamine 908 molecules in Fig. 3 . Nanoparticle-mediated complement activation in human serum/plasma. Some NPs trigger complement activation via multiple pathways. In some cases, complement activation through classical and lectin pathways triggers the ampli cation loop of the alternative pathway. fi close proximity may transiently resemble structural motifs of D-mannose/NAcGlc (in terms of oxygen and carbon atom sequences and spacing), thereby acting as docking sites for MBL, colins and collectin fi 11. The mechanisms by which carbon nanotubes coated with methoxypoly(ethylene glycol)-phospholipid conjugates trigger the lectin pathway are not clear . It is plausible that these nanotubes [198, 199] may trigger the lectin pathway non-speci cally through direct refi cognition of the glycosylated regions of plasma proteins ( , apolipoe.g. proteins and certain classes of antibodies) that have been adsorbed from plasma onto nanotube surfaces by the lectin pathway sensing molecules (MBL, colins, and collectin 11). fi
The alternative pathway
The alternative pathway is triggered on spontaneous hydrolysis of the thiolester in C3 to form C3 (H 2 O) . The latter binds [166, 168] complement factor B forming C3(H 2 O)B. The bound factor B is then cleaved by factor D to form C3(H 2 O)Bb, which is the uid-phase C3 fl convertase, cleaving C3 into C3a and C3b. Surface-bound C3b binds factor B, which is in turn cleaved by factor D to form C3bBb, which is an unstable alternative pathway C3 ampli cation convertase. This confi vertase, however, become stabilised on binding to properdin forming C3bBbP, which also cleaves C3 into C3a and C3b
. This [166, 168] provides a positive feedback ampli cation loop causing more C3b defi position on surfaces. The ampli cation loop is regulated by complement fi factors H and I
. There are also links between the lectin and al- [168] ternative pathways. For instance, there are indications that MASP1 can cleave C3 directly . MASP3 has also been identi ed as a pro-factor [204] fi D activator in resting blood . [205] Many nanoparticle types trigger the alternative pathway either directly or through the ampli cation loop, where the surface may have fi initially triggered complement through calcium-sensitive pathways [176,180 182,184,185,190,198 203,206 208] ---. However, in some cases C3(H 2 O) may deposit directly, and in a non-covalent fashion, on NP surfaces . This also initiates C3 cleavage through subsequent [209] binding of factors B and D. A recent study has further shown that dextran and poly(ethylene glycol) stabilised NPs can trigger the alternative pathway indirectly through non-speci c plasma protein adfi sorption . On surface adsorption, plasma proteins may undergo [210] thermodynamic and conformational changes. This could expose reactive domains/groups susceptible to C3b attack, thereby forming C3bBb and C3bBbP convertases bound to surface-adsorbed proteins. Interestingly, this process was found to be continuous and changeable in vivo; protein-complement complexes were formed on the NP surface and then released and the cycle repeated on further plasma protein deposition . Accordingly, this may be a non-speci c general me- [210] fi chanism by which NPs (regardless of their chemical composition and make up) could increase the turnover of the alternative pathway, and limiting the action of complement regulatory proteins factor H and I to stop complement activation. This continuous C3b binding and release may further explain why long-circulating NPs are slowly recognised and cleared from the blood by the liver and spleen macrophages [172, 180, 208, 211] .
Complement non-activating surfaces
There are also examples of many NPs, which are poor activators of the complement system. These include carbon nanotubes coated with poly(maleic anhydride-alt-1-octadecene) that is attached to two molecules of methoxypoly(ethylene glycol)5000
, lyotropic non-la- [199] mellar liquid crystalline aqueous dispersions of citrem/glycerylmonooleate , liposomes with incorporated L-glutamic acid [212, 213] and -(3-carboxy-1-oxopropyl)-,1,5-dihexadecyl ester in their bilayer N [214] [215] , and lipid-NPs coated with hyaluronan . The molecular basis of these observations has not been fully elucidated, but it appears to be regulated by surface recruitment of the complement regulatory protein factor H. There are also examples of various NPs that have been surface engineered with complement inhibitors such as factor Hbinding peptides to overcome complement activation, and to modulate their pharmacokinetics . Finally, attempts that minimise non- [216, 217] speci c protein deposition on NPs may further prevent complement fi activation through the alternative pathway . [218] 6. Role of size, shape and exibility of nanoparticles
The mononuclear phagocyte system (MPS) is considered as the major biological barrier that needs to be overcome in the systemic administration of NP for drug delivery to non-phagocytic cells. Following intravascular injection, the uptake of NPs by cells of the MPS severely limits NP lodging within the diseased tissues. Phagocytic cells, predominantly macrophages residing in tissues in contact with the blood, tend to recognise NPs as foreign objects and sequester them rapidly from the blood. Thus, resident phagocytic cells, like Kup er ff cells in the liver, the splenic marginal zone and red pulp macrophages, persinal bone marrow macrophages (species-dependent) and the pulmonary intravascular macrophages (PIMs) in the lungs (species-dependent), rapidly remove signi cant amounts of NPs from the blood fi circulation . In oncological applications, a signi cant fraction of [176] fi the injected dose of NPs accumulates in the reticuloendothelial organs, particularly the liver and spleen, whereas only a small amount lodges steadily within the tumour tissue . Despite continuous e orts over [219] ff the last decade, devoted to alleviate the rapid clearance of circulating NPs, escaping MPS continues to be a major issue. Today, the dominant strategy relies on coating NPs with su ciently large densities of PEG or ffi related polymers/block copolymers. More recently, the notion that NP deformability could be exploited to limit particle recognition and sequestration by cells of the MPS was consistently being demonstrated by several laboratories . [220, 221] 
Nanoparticle internalisation mechanisms
Phagocytosis is the primary mechanism for NPs uptake by macrophages. However, other cellular mechanisms are also involved depending on the NP size, shape and surface properties. The general term endocytosis is referred to as an active transport mechanism across the cell membrane. Endocytosis encompasses receptor-independent macropinocytosis, and receptor-dependent clathrin-dependent endocytosis and a number of clathrin-independent mechanisms (lipid raft-independent phagocytosis, caveolin-independent lipid raft-mediated endocytosis, lipid raft-dependent caveolin-mediated endocytosis, and micropinocytosis)
. Through macropinocytosis and dorsal [222 224 ] -ru es, cells uptake particles with a characteristic size ranging from 0.5 ffl to 5.0 m. For smaller NPs, in the 20 500 nm, both clathrin-dependent -and clathrin-independent mechanisms are primarily involved. Clathrindependent mechanisms are active in the uptake of particles < 150 nm, while clathrin-independent caveolin-dependent endocytosis is mostly responsible for the uptake of small NPs particles < 80 nm . On the [223] other hand, larger particles, typically > 5 m, are taken up by cells of the MPS through phagocytosis . [225, 226] A necessary condition for internalisation is the rm adhesion of NPs fi onto the cell surface, which is mediated by attributes such as size, shape and surface properties . With regard to the surface proper- [227 230 ] -ties, an important factor facilitating NP adhesion and internalisation by receptor-dependent endocytic mechanisms is opsonisation, which derives from the adsorption of blood proteins on the NP surface [10,12, 231 234] -. Following the intravenous administration of NPs, a plethora of plasma proteins adsorb onto the NP surface forming an outer shield commonly referred to as the protein corona. Main components of protein corona are apolipoproteins, immunoglobulins and complement components . This coating process (opsonisation) [233] may facilitate the recognition of circulating NPs by cells of the MPS through the binding with cell receptors speci cally expressed on the fi surface of phagocytic cells . Upon receptor binding (in particular [234] Fc receptors), MPS cells tend to envelop NPs into a endocytic zipper-like membrane, which trap them into intracellular vesicles and drag them deeper into the cell body by an actin bre-dependent process . fi [226] Once internalised, the cell vesicles containing the NPs fuse with a lysosome, where NPs are exposed to hydrolytic enzymes , which [223] eventually would mediate the dissolution of any biodegradable materials. In order to prevent NP sequestration by cells of the MPS, a key requirement is to avoid, or at least delay, the physical encounter between NPs and macrophages . [176] 6.2. Nanoparticle size, shape and surface properties Currently the main strategy for modulating NP recognition and subsequent sequestration by macrophages is based on limiting the absorption of serum protein on the NP surface by building a steric barrier with projected hydrophilic polymer chains. Limiting opsonisation is best achieved by tuning the surface hydrophilicity and hydrophobicity of NPs. By far, the most common approaches are based on decorating the NP surface with PEGs , polysaccharides such as dextrans, [235, 236] and combinations thereof . Even though PEG surface decoration [185] can reduce NP uptake by macrophages, it is generally far from being a de nitive solution. Indeed, while it has been commonly believed that fi PEGylation of particle surfaces serves to reduce non-speci c engulfment fi by virtue of minimising protein adsorption, several reports have provided evidence that the adsorption of speci c proteins (dysopsonins) fi onto the surface of polymer-coated NPs is required for their stealthi-" ness . " [15, 237] The rate by which phagocytic cells engulf NPs changes with the geometrical properties of the latter. Generally, spherical particles of 50 200 nm are generally rapidly ingested by macrophages.
Fundamental information on the role played by NP size and shape on macrophage internalisation were provided in recent studies [176,238 240] -. For instance, the importance of NP size and shape combination in phagocytic processes was underlined in the study by Paul ., where the physical mechanisms regulating phagocytosis et al were explored probing whether and how the NP size and shape would a ect uptake . However, opsonisation was not taken into account ff [227] in this study. Speci cally, the engulfment times from a large number of fi single phagocytosis events obtained using various spherical NPs and one ellipsoidal NP type was measured. The study shows that spherical NPs with larger surface areas were engulfed by RAW264.7 cells ve fi times faster than ellipsoids with a small eccentricity, just 0.954. Similar conclusions were documented in the work of Banerjee ., in which et al worm-like particles are demonstrated to avoid macrophage phagocytosis more e ciently than spherical beads . Also, other works ffi
[241] conducted with polymeric particles provided similar con- [238 240 ] -clusions on the role of size and shape in modulating macrophage uptake. Speci cally, it was reported that ellipsoidal particles were phafi gocytosed less e ciently when compared to conventional spherical ffi particles of equal volume [240] . The notion that non-spherical NPs can resist internalisation more than spherical was already mathematically predicted and appears to be independent of the materials con- [229] stituting the NP. Indeed, studies have shown that also gold nanorods are taken up by macrophages at lower rates as compared to gold nanospheres . It should be here emphasized that internalisation of NPs [242] requires macrophages to activate actin remodelling, which is an energy consuming process. The dependence of phagocytosis on particle shape could be linked to the extent of actin remodelling required by the cellular cytoskeleton in order complete the process. Therefore, shapes requiring more actin remodelling should be less prone to internalisation by phagocytic cells . Doshi . investigated the importance of [240] et al target geometry in recognition by immune cells using di erent polyff meric particles that represent the size and shape range of a variety of bacteria. These studies reported that attachment of particles with different geometries to macrophages was strongly dependent on their size and shape combinations , con rming again what was mentioned [239] fi above. Furthermore, recently Wibroe . presented two di erent apet al ff proaches to reduce rapid particle clearance by PIMs in pigs. In one strategy, 500 nm spheres, 450 × 120 nm rods and 250 × 75 nm disks were directly injected in pigs in order to compare their behain vivo viour. It was found that the spherical particles were more rapidly cleared from the blood compared with non-spherical particles. The second strategy was based on attaching polystyrene particles to the surface of erythrocytes (erythrocyte "hitch-hiking") prior to systemic injection. By doing so the authors could show clearance regardless of complement system . [176] Similar to the latter strategy, others have attempted to coat NPs with cell membranes of membrane components. Examples of these procedures include NPs coated by leukocyte membranes , and NPs [243] decorated with CD47 antigens . These technologies can extend the [244] circulating time of NPs, as compared to unmodi ed NPs, but quantifi tative data on accumulation within the liver, spleen and lungs in vivo are still unavailable and, as such, a clear understanding of MPS avoidance is still lacking.
Nanoparticle deformability
Besides size, shape and surface properties, NP deformability has recently emerged as a novel parameter capable of modulating recognition and sequestration by the MPS. Not all materials used in nanomedicine allows for a precise tuning of NP deformability. Polymers, colloidal hydrogels or layer-by-layer (LbL)/templated capsules are mostly used
, as compared to core-shell NPs, which contain a [245 252 ] -solid polymeric core stabilised by a lipid shell or polymer brushes [253 255] -. The idea of producing more exible particles is biologically fl inspired to the recent discoveries by Sosale . about red blood cell et al (RBC) clearance by splenic macrophages. Macrophages are capable of sensing the smallest di erences in the elasticity of objects they enff counter. RBC are selectively removed from blood circle by splenic macrophages subsequent to small changes of their elasticity . The [256] loss of RBC deformability is in fact one of the factors contributing to their removal from blood circle. The fast internalisation of rigid RBC is consistent with the rapid clearance of apoptotic bodies, which are rigid [256] , a phenomenon that leads to think that MPS preferentially internalise rigid objects.
Anselmo et al . demonstrated that J774 cells internalised rigid 200 nm PEG-based hydrogels 4-fold more e ciently in comparison to ffi the soft counterpart . The same trend was observed in another [257] study in which much larger (1-6 m) polyacrylamide particles were used. Mouse bone marrow-derived macrophages internalised rigid particles 6-fold more than their soft counterparts . The process [258] seems to be due to the di culty for actin laments to locate at the ffi fi interface between NPs and cell. In the same paper it is described the possible interplay between opsonisation and elasticity, since without pre-opsonisation the internalisation di erence between rigid and soft ff particles disappears. Notably, a recent mechanistic analysis revealed that the route of entry of 150-200 nm hydrogel NPs can change according to particle sti ness. In a recent study, it was revealed that soft ff particles were internalised preferentially macropinocytosis, while via rigid particles were mostly internalised a clathrin-dependent mevia chanism . Interestingly, particles with intermediate elasticity were [259] internalised by both mechanisms. In another study, it is demonstrated that harder cubic and spherical LbL particles were internalised over 10-fold more e ciently than their softer counterparts by J774 macroffi phage-like cells. Despite the di erent shape, rigid particles were still ff internalised to a signi cantly higher extent . Decuzzi . studied fi [260] et al di erences in terms of sequestration by macrophages of discoidal ff polymeric nanoconstructs (DPNs) . The authors generated two [261] di erent types of particles, identical for their surface chemistry and ff shape but with di erent rigidity, and compared their performance ff in vitro in vivo In vitro and . , rigid disks were taken up to 3 fold more e ciently by mouse bone marrow-derived macrophages and macroffi phage-like cell lines as compered to their soft counterpart ( ). Fig. 4 In vivo data revealed that soft particles accumulated in the liver of tumourbearing mice at a signi cantly lower extent. The reduced uptake by fi liver allowed for an enhanced circulation half-life and for an increased tumour vasculature targeting . The extended circulation half- [221, 261] life of deformable particles was also shown in previous studies [262, 263] .
It should be emphasized that soft particles are more easily deformed by cells during the phagocytic process, as compared to rigid particles. This deformation can be responsible for local changes in shape and orientation of ligand molecules thus making the internalisation process less energetically favourable . [264] 7. Concluding remarks Engineered nanoparticles can interact with the immune system in many di erent ways. Here we discussed how NPs interact with some of ff the key players of the innate immune system including monocytes/ macrophages, neutrophils and other granulocytes, and dendritic cells. We also explored the interaction of NPs with soluble components of the innate immune system, , complement components. One may broadly i.e. classify the cellular interactions of NPs into those that lead to a direct cytotoxicity and those interactions that a ect immune cell function in ff the absence of overt cell death. Studies in recent years have shed light on the mechanisms underlying some of these interactions, such as inflammasome activation. Other areas remain to be explored, including the potential impact of NPs on innate immune memory. The other side of the coin is that the same immune cell interactions that account for the hazardous e ects of NPs could potentially be exploited in a clinical ff setting. For instance, targeting NPs to monocytes or macrophages could enable novel therapeutic and/or diagnostic approaches. Smith . et al [265] reported that, in addition to conventional uptake mechanisms, single-walled carbon nanotubes were almost exclusively taken up by a single immune cell subset, Ly-6C hi monocytes, and delivered to tumours in mice. The remarkable selectivity suggests a novel, Trojan horse-type delivery strategy for enhancing speci c tumour delivery of relevant fi cargoes, through exploitation of speci c immune cell interactions. fi Furthermore, Miller . showed that NPs comprising a platinum et al [266] (IV) pro-drug and a PLGA-based polymer platform promoted long drug circulation and altered accumulation by directing cellular uptake toward tumour-associated macrophages (TAMs). Simultaneous imaging of NPs, the drug payload and DNA damage responses revealed that TAMs served as a local drug depot with gradual release to neighbouring tumour cells. In addition, NPs may be deployed in vaccination strategies, as delivery vehicles for antigen and/or as adjuvants , per se Fig. 4 . Macrophage uptake of soft and rigid discoidal polymeric nanoconstructs. Confocal microscopic analysis of macrophage-like RAW267.4 cells (red, Wheat Germ Agglutinin staining of cell membrane; blue, DAPI staining of cell nucleus). Cells were exposed for 4 h to discoidal polymeric constructs (DPNs; green) of di erent riff gidity (soft, left panels; rigid, right panels). Lateral projections and 3D views allow a precise localisation of DPNs with respect to the cell membrane. Theblending rendering (lower panels) allows to visualise the position of particles respect to the cell membrane (arrows): the soft particle is visible over the cell membrane (lower left), whereas the rigid particle is not visible as it is located below the cell membrane (lower right).
capitalising on their propensity for uptake by DCs and other antigenpresenting cells . [267] There are numerous remaining challenges, however, before NP interactions with the innate immune system are properly understood. Not only do material properties such as size, shape, surface charge, softness (deformability) play a role for NP interactions with the immune system, but the adsorption of proteins or other biomolecules onto the surface of NPs also in uences their subsequent interactions with macrophages and fl other immune cells . Furthermore, surface modi cation of NPs [268] fi may in uence the formation or composition of the bio-corona, but this fl may also have an impact on cellular interactions; careful design of NPs is thus required to tune these interactions. In addition, the contamination of NPs with bacterial LPS or other PAMPs is more than an academic question: endotoxin contamination of any medical product or device must be carefully controlled. Finally, attention should also be given not only to the characterisation of the test material, but also to the suitability of the model system(s) used when studying immune interactions of engineered NPs. Both and systems have in vitro in vivo advantages and disadvantages, but it is important to consider that most model systems do not re ect the tremendous degree of human immune fl system variation that exists between individuals. The human immune system can vary as a consequence of heritable and non-heritable influences, including symbiotic or pathogenic microbes . Model [269] systems that re ect the range of di erent human "immunotypes" fl ff [270] may therefore be useful. 
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